For Central Asian countries, the current demographic situation presents a unique opportunity for economic growth. With a ...

US equities gained on strong Q3 earnings while China markets declined. China's GDP data and US CPI readings will influence ...

Earlier this month, Brookfield Global Transition Fund II closed at a record US$20 billion, with additional co-investments bringing the total to over US$23 billion. And in a move that’s likely to ...

Let’s examine the recent performance, growth outlook, dividend-growth history, and yields of BCE and Telus to determine which is the better buy right now. The post Interested in BCE Stock? Look at ...

Donald Trump is often blamed for the US’s hostility toward the EU, but the roots of the rift run deeper. Europe’s ...

See if Templeton Emerging Markets Income Fund (TEI) is worth holding. Learn about its 9.1% yield, NAV growth challenges and ...

Falling Fed rates and favorable policies make XLV a strong healthcare ETF pick. Read here for an analysis of its growth ...

Infosys has also increased the lower end of its guidance from 1% to 2%, while FY26 revenue guidance stands at 2%-3% in ...

Asia has proved unexpectedly resilient, aided by a front-loading of exports, technology investment, and policy support. Now ...

A new policy discussion led by Brookings and Co‑Develop is calling for a fundamental rethink of how multilateral development ...

Weight-loss drug stocks, including Novo Nordisk, Eli Lilly, Viking Therapeutics, Amgen, and Altimmune, face political scrutiny and market volatility following President Trump’s remarks on pricing ...

ESTIC-2025 is designed as a translation platform. It brings together government ministries and departments, laboratories and ...